Gary Tarshis
Family Medicine · Colorado Springs, CONPI 1861436503
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $6,776 of the $10,168 with a category attached, or 66.6%. 22 manufacturers reported payments, led by Astrazeneca UK Limited at 24.3% of the total. Among family medicine clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 83 payments — averaging $122.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astrazeneca UK Limited$2K
- Merck$2K
- Genentech USA, Inc.$2K
- Boehringer Ingelheim$1K
- Sanofi$336
- AstraZeneca$248
- plus $1K from 16 others
Across 4 payments — averaging $329.88 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- GSK$1K
- Merck$169
- Cipla USA Inc.$54
What the payments were for
- Travel & lodging$6,77667%
- Food & beverage$3,39233%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astrazeneca UK Limited | 10 | $2,467 |
| Merck | 14 | $2,435 |
| Genentech USA, Inc. | 6 | $2,299 |
| Boehringer Ingelheim | 8 | $1,132 |
| Sanofi | 5 | $336 |
| AstraZeneca | 2 | $248 |
| Johnson & Johnson | 6 | $224 |
| Genentech, Inc. | 3 | $185 |
| Pfizer | 2 | $123 |
| AbbVie | 2 | $116 |
| Ardelyx, Inc. | 5 | $112 |
| Janssen Scientific Affairs, LLC | 1 | $103 |
| Madrigal Pharmaceuticals | 4 | $93 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $63 |
| Regeneron Healthcare Solutions, Inc. | 3 | $61 |
| Gilead | 2 | $48 |
| Intercept Pharmaceuticals, Inc. | 2 | $31 |
| Nestle Healthcare Nutrition Inc. | 1 | $21 |
| QOL Medical, LLC | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Ferring Pharmaceuticals Inc. | 1 | $17 |
| Aimmune Therapeutics, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DUPIXENT$147
- Tremfya$132
- Non-Covered Product$108
- STELARA$103
- REMICADE$103
How this compares
$10,168 in reported general payments places this provider in the 95th percentile of 2,079 family medicine providers in Colorado.
Other family medicine in Colorado Springs
- Matthew YoungColorado Springs$270K
- Lawrence AndrewsColorado Springs$102K
- Elizabeth EricksonColorado Springs$31K
- Daniel RohwederColorado Springs$21K
- Jeremy BrownColorado Springs$8K
- Ethan LazarusDenver$688K
- Michael de NardisLarkspur$335K
- Mark DeutchmanDenver$258K
- Kari UusinarkausWoodland Park$254K
- Michael MeekerUsaf Academy$174K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.